What are “turbo cancers,” and is this a new phenomenon that we should be aware of? This term has been coined to describe cancers that grow at an unusually rapid pace, making them much more challenging to treat. What’s more, with the aggressive nature of these diseases, the race against time becomes even more critical.
Are we seeing a rise in these fast-growing cancers – and what are scientists doing to address this issue? Let’s explore…
In this episode, we have the pleasure of sitting down with Dr. Harvey Risch, a leading authority in the field of cancer and infectious disease research. As a Professor Emeritus of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine, his research interests center around cancer etiology, prevention and early diagnosis, and epidemiologic methods.
From ovarian cancer to lung cancer, Dr. Risch is committed to enhancing the way we approach chronic diseases. What makes his perspective so unique? Join us to learn for yourself!
Hit play to discover:
- The percentage of cancers that are considered turbo cancers.
- Factors that contribute to the development of cancer.
- The role that big pharma plays in the current state of public health.
- How to source reliable medical information despite the corruption of the government and media.
For more insights and updates on Dr. Risch's research, we encourage you to connect with him on Twitter or Telegram. This is an excellent opportunity to stay informed and engage directly with his work!
Episode also available on Apple Podcasts: http://apple.co/30PvU9
